USANA Health Sciences, Inc. (NYSE:USNA) Stock Holdings Increased by Panagora Asset Management Inc.

Panagora Asset Management Inc. raised its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 143.1% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,881 shares of the company's stock after buying an additional 16,999 shares during the period. Panagora Asset Management Inc. owned about 0.15% of USANA Health Sciences worth $1,307,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Bank of New York Mellon Corp boosted its holdings in USANA Health Sciences by 5.6% in the second quarter. Bank of New York Mellon Corp now owns 97,375 shares of the company's stock worth $4,405,000 after purchasing an additional 5,205 shares in the last quarter. Assenagon Asset Management S.A. lifted its holdings in USANA Health Sciences by 32.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 109,252 shares of the company's stock worth $4,943,000 after purchasing an additional 27,053 shares during the last quarter. SG Americas Securities LLC acquired a new position in USANA Health Sciences during the second quarter valued at approximately $340,000. First Hawaiian Bank raised its position in shares of USANA Health Sciences by 36.9% in the second quarter. First Hawaiian Bank now owns 12,439 shares of the company's stock valued at $563,000 after purchasing an additional 3,350 shares during the period. Finally, Jacobs Levy Equity Management Inc. raised its position in shares of USANA Health Sciences by 2.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 111,492 shares of the company's stock valued at $5,407,000 after purchasing an additional 2,820 shares during the period. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Trading Up 0.4 %

Shares of USNA traded up $0.18 during trading hours on Friday, hitting $40.82. 63,008 shares of the stock traded hands, compared to its average volume of 71,767. The firm has a market capitalization of $777.62 million, a PE ratio of 12.72, a price-to-earnings-growth ratio of 1.36 and a beta of 0.90. USANA Health Sciences, Inc. has a 1-year low of $37.35 and a 1-year high of $65.27. The business has a fifty day moving average of $42.69 and a 200-day moving average of $45.45.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.11). USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. The business had revenue of $212.87 million during the quarter, compared to analyst estimates of $218.64 million. During the same quarter in the prior year, the company earned $0.89 earnings per share. As a group, equities research analysts expect that USANA Health Sciences, Inc. will post 2.5 earnings per share for the current fiscal year.

Insider Activity at USANA Health Sciences

In other news, major shareholder Myron W. Wentz sold 3,700 shares of the firm's stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $48.61, for a total transaction of $179,857.00. Following the completion of the sale, the insider now owns 7,880,043 shares in the company, valued at approximately $383,048,890.23. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, major shareholder Myron W. Wentz sold 2,202 shares of USANA Health Sciences stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $47.79, for a total transaction of $105,233.58. Following the completion of the sale, the insider now owns 7,877,841 shares of the company's stock, valued at $376,482,021.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Myron W. Wentz sold 3,700 shares of the company's stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $48.61, for a total transaction of $179,857.00. Following the completion of the transaction, the insider now owns 7,880,043 shares in the company, valued at $383,048,890.23. The disclosure for this sale can be found here. In the last ninety days, insiders sold 27,338 shares of company stock worth $1,204,486. Insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on USNA. DA Davidson dropped their target price on shares of USANA Health Sciences from $46.00 to $38.00 and set a "neutral" rating on the stock in a research report on Thursday, July 25th. StockNews.com lowered shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Wednesday, July 24th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.